Mark Wingertzahn is CSO at Wesana Health. Dr Wingertzahn is the Instructor of Pediatrics at NYU (Medicine) and Associate Professor of Life Sciences & Allied Health at the NY Institute of Technology College of Osteopathic Medicine.
Previously, he has led Medical and Scientific Affairs and Clinical Development teams at both GSK and Pfizer.
Dr Wingertzhan is also currently Senior Vice President of R&D and Head of Development at Kaleido Biosciences.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)